Table 3. Equilibrium dissociation constants (Kd, µM) for aminoglycosides to TAR-2′pyr(25) in the presence of nucleic acid competitors.
Minimal conditionsa | ‘Physiological’ conditionsb | |||||
---|---|---|---|---|---|---|
No competitor | +dsDNAc | +tRNAmixd | No competitor | +dsDNAc | +tRNAmixd | |
Neomycin B | 5.8 ± 1 | 14 ± 3 | 94 ± 12 | 9.0 ± 1 | 15 ± 5 | 84 ± 18 |
Tobramycin | 43.4 ± 4 | 44 ± 6 | 115 ± 7 | 22 ± 4 | 44 ± 2 | 137 ± 10 |
Kanamycin A | 107 ± 13 | 142 ± 2 | 141 ± 2 | 84 ± 15 | 122 ± 13 | 157 ± 25 |
a50 mM Tris pH 7.4, 100 mM NaCl, 1 mM MgCl2.
b30 mM HEPES pH 7.4, 100 mM KCl, 10 mM Na2HPO4, 20 mM guanidinium HCl, 2 mM MgCl2, 20 mM NaCl, 0.5 mM EDTA, 0.001% non-ionic detergent P-40.
cdsDNA competitor sequence: 5′-GCTGAATACATAAGACG-3′, and its complement.
dIndicate apparent Kd (see text).